ProPhase Labs (PRPH) Receivables - Net (2010 - 2026)
ProPhase Labs (PRPH) recorded Receivables - Net of $1.54 million in Q2 2026, down 92.3% from $20.09 million a year earlier and unchanged from the prior quarter.
Analysis
ProPhase Labs (PRPH) Receivables - Net (2010 - 2026) Analysis & Trends
Starting with Q4 2010, ProPhase Labs' Receivables - Net history includes 61 quarters.
- Annual Receivables - Net has declined for four straight years, with a five-year compound annual growth rate of -13.4% (FY2020 to FY2025).
- Across earlier years, Receivables - Net came in at $20.06 million in FY2024 (-44.0%), $35.81 million in FY2023 (-3.3%), $37.05 million in FY2022 (-1.7%) and $37.71 million in FY2021.
- Quarterly Receivables - Net has ranged from $1.54 million in Q4 2025 to $38.64 million in Q3 2023 over the past five years.
- On a year-over-year basis, Receivables - Net has declined for 11 consecutive quarters, with an average decline of 63.8% over the last eight quarters.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 451.9% in Q2 2022, against a decline of 92.4% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.54 million (Q1 2026), $1.54 million (Q4 2025) and $3.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | ProPhase Labs | 155,925.56 | -390,074.44 | 226,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 20.09 Mn |
| Mar 31, 2025 | 20.20 Mn |
| Dec 31, 2024 | 20.06 Mn |
| Sep 30, 2024 | 31.64 Mn |
| Jun 30, 2024 | 32.94 Mn |
| Mar 31, 2024 | 35.12 Mn |
| Dec 31, 2023 | 35.81 Mn |
| Sep 30, 2023 | 38.64 Mn |
| Jun 30, 2023 | 38.57 Mn |
| Mar 31, 2023 | 37.84 Mn |
| Dec 31, 2022 | 37.05 Mn |
| Sep 30, 2022 | 37.83 Mn |
| Jun 30, 2022 | 36.67 Mn |
| Mar 31, 2022 | 36.69 Mn |
| Dec 31, 2021 | 37.71 Mn |
| Sep 30, 2021 | 10.68 Mn |
API Access
ProPhase Labs Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=PRPH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();